When was Chiaro founded?

Chiaro was founded in 2013 and raised its 1st funding round within a year of its incorporation.

Where is Chiaro located?

Chiaro is headquartered in London, United Kingdom.

How many employees does Chiaro have?

As of Sep 30, 2020, the latest employee count at Chiaro is 87.

Is Chiaro a funded company?

Chiaro is a funded company, having raised a total of $1.8M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 01, 2013.

When was the latest funding round of Chiaro?

Chiaro's latest funding was a $***** Series A round on May 01, 2014, with participation from 0 investor. Its primary sector is Wearable Technology. Globally, the Wearable Technology sector has seen $1.52B in funding in 2026 to date.

Where does Chiaro rank among its competitors?

Chiaro ranks 5th amongst 28 active competitors, of which 5 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was COSM, which secured an undisclosed amount in Jun, 2025.

Who are the top competitors of Chiaro?

Chiaro's top competitors include Fizimed, COSM and Atlantic Therapeutics. Among them, COSM secured the most recent funding round in June, 2025.

Chiaro - 2026 Company Profile, Team, Funding & Competitors

Company Details

Chiaro has developed Elvie - a personal trainer for women to strengthen pelvic floor muscles. Strong pelvic floor muscles provide stability to the whole pelvic region and lower spine. Weak ones can lead to incontinence and prolapse - particularly in women after childbirth and menopause. Multiple sensors measure the amount of pressure being applied and how, and this information is relayed via Bluetooth to a mobile app to offer real-time feedback that lets women improve their technique and strength score.

Key Metrics

Founded Year

2013

Location

London, United Kingdom

Stage

Series A

Total Funding

$1.8M in 2 rounds

Latest Funding Round

Series A, May 01, 2014, $*****

Investors

Elkstone

Ranked

5^th among 28 active competitors

Employee Count

87 as on Sep 30, 2020

Similar Companies

Atlantic Therapeutics & 19 more

View Chiaro's full profile

Chiaro is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CHIARO CIN: 40103963074 , Latvia, Active	Jan 21, 2016	€0 - €1M (As on Dec 31, 2024)	7 (As on Dec 31, 2023)	-
Chiaro Technology Limited CIN: 8502405 , United Kingdom, Active	Apr 23, 2013	£50M - £100M (As on Dec 31, 2021)	243 (As on Dec 31, 2022)

Chiaro has raised a total funding of $1.8M over 2 rounds. Its first funding round was on Dec 01, 2013. Chiaro has 1 institutional investor.

Here is the list of recent funding rounds of Chiaro:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 01, 2014	7254917	Series A	8292470	4391097	3005812	7769434
Dec 01, 2013	9691734	Seed	7895352	8638455	3373420	6270076

Access funding benchmarks and valuations. Sign up today!

View details of Chiaro's funding rounds and investors

The founders of Chiaro are Alexander Asseily and Tania Boler.

Here are the details of Chiaro's key team members:

Alexander Asseily: Co-Founder & Chairman of Chiaro and founder of 9 other companies, including Zulu Group, Zulu Ecosystems and Elvie. They are also an angel investor in 4 startups and serve on the boards of 2 companies.
Contact Info: 1 email address
Tania Boler: Founder, CEO of Chiaro.

View details of Chiaro's Founder profiles and Board Members

Chiaro's employee count trend

Chiaro has 87 employees as of Sep 20. The total employee count is 58.0% more than what it was in Sep 19. Here is Chiaro's employee count trend over the years:

Uncover Chiaro's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Chiaro include Fizimed, COSM and Atlantic Therapeutics. Here is the list of Top 10 competitors of Chiaro, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Fizimed 2017, Strasbourg (France), Series A	Manufacturer of device for controlling urinary leakage	$4.35M	UNIQA Group, UI Investissement & 2 others	58/100
2nd	COSM 2017, Toronto (Canada), Seed	Provider of devices for women pelvic floor disorder	$5.65M	iGan Partners, Fusion Fund & 8 others	58/100
3rd	Atlantic Therapeutics 2013, Oranmore (Ireland), Acquired	Developer of a non-invasive wearable device for pelvic floor strengthening and nerve stimulation products	$70.6M	Life Sciences Partners, Western Development Commission ... & 10 others	48/100
4th	Perifit 2016, Paris (France), Unfunded	App and smart exerciser for pelvic floor strength training	-	-	46/100
5th	Chiaro 2013, London (United Kingdom), Series A	Device to strengthen pelvic floor muscles	$1.8M	Elkstone	43/100
6th	Renovia 2016, Boston (United States), Series C	Developer of e-stimulation device and tools for the strengthening of pelvic floor muscles	$57.5M	Parian Global Management, Perceptive Advisors ... & 9 others	43/100
7th	Elidah 2014, Monroe (United States), Seed	Provider of non-invasive home device for strengthening pelvic muscles control	$2.02M	National Science Foundation, Connecticut Innovations ... & 2 others	41/100
8th	URGO Mia 2018, Roubaix (France), Unfunded	Internet first brand offering product for the perineum	-	-	36/100
9th	Empelvic 2018, Copenhagen (Denmark), Acquired	Provider of pelvic floor training device for women	-	-	35/100
10th	kGoal Wahroonga (Australia), Unfunded	Provider of wearable devices to track pelvic fitness for women	-	-	33/100